1. Cyclooxygenase-2 Expression in Primary and Recurrent Pterygium
- Author
-
Tuba Karabacak, Leyla Cinel, Özay Öz, Ayça Sari, and Ufuk Adigüzel
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Conjunctiva ,040301 veterinary sciences ,Conjunctival Tumor ,Conjunctival Neoplasms ,Pterygium ,Immunoenzyme Techniques ,0403 veterinary science ,03 medical and health sciences ,Recurrence ,Humans ,Medicine ,Recurrent pterygium ,biology ,business.industry ,04 agricultural and veterinary sciences ,General Medicine ,medicine.disease ,Primary and secondary antibodies ,eye diseases ,Staining ,Ophthalmology ,030104 developmental biology ,medicine.anatomical_structure ,Cyclooxygenase 2 ,biology.protein ,Immunohistochemistry ,sense organs ,Cyclooxygenase ,business ,Biomarkers - Abstract
Purpose Pterygium is a proliferative, inflammatory, and invasive ocular surface disease associated with excessive ultraviolet radiation exposure and has several tumor-like characteristics. Cyclooxygenase-2 (COX-2) is an inducible enzyme and recently increased expression of the enzyme was found in many cancers and premalign lesions. This study was conducted to identify the COX-2 expression in pterygium tissues. Methods Immunohistochemical staining using a primary antibody for COX-2 was performed on 30 specimens with primary pterygium (20 pterygium without recurrence and 10 pterygium which recurred during a 12-month follow-up), 11 specimens with recurrent pterygium, and 8 specimens of conjunctival tumor. As a control we used 10 specimens of normal conjunctiva. Extent and intensity of cytoplasmic and membranous staining in epithelial cells were evaluated. Results Higher expression of COX-2 was detected in conjunctival tumor (87.5%) specimens and recurrent pterygium specimens (72.7%) compared to the both normal conjunctiva (30%) and primary pterygium without recurrence (30%). COX-2 expression in primary pterygium tissues with recurrence (60%) was not different from primary pterygium without recurrence (p=0.114) and recurrent pterygium (p=0.537). However, recurrent pterygium tissues were found to express higher COX-2 than primary pterygium without recurrence (p=0.022). Conclusions COX-2 expression is increased in recurrent pterygium tissues and COX-2 expression may be a marker for the prediction of recurrence.
- Published
- 2007
- Full Text
- View/download PDF